Financial Analysis: Biodesix (NASDAQ:BDSX) versus First Choice Healthcare Solutions (OTCMKTS:FCHS)

Biodesix (NASDAQ:BDSXGet Free Report) and First Choice Healthcare Solutions (OTCMKTS:FCHSGet Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, valuation, analyst recommendations, institutional ownership and dividends.

Earnings & Valuation

This table compares Biodesix and First Choice Healthcare Solutions”s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Biodesix $49.09 million 2.48 -$52.15 million ($0.39) -2.15
First Choice Healthcare Solutions $30,000.00 7.36 -$8.17 million N/A N/A

First Choice Healthcare Solutions has lower revenue, but higher earnings than Biodesix.

Profitability

This table compares Biodesix and First Choice Healthcare Solutions’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Biodesix -66.84% -275.79% -43.05%
First Choice Healthcare Solutions -9,943.78% N/A -123.38%

Volatility & Risk

Biodesix has a beta of 1.06, suggesting that its share price is 6% more volatile than the S&P 500. Comparatively, First Choice Healthcare Solutions has a beta of 0.87, suggesting that its share price is 13% less volatile than the S&P 500.

Insider & Institutional Ownership

21.0% of Biodesix shares are owned by institutional investors. 69.2% of Biodesix shares are owned by company insiders. Comparatively, 30.8% of First Choice Healthcare Solutions shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of current recommendations for Biodesix and First Choice Healthcare Solutions, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Biodesix 0 0 5 0 3.00
First Choice Healthcare Solutions 0 0 0 0 0.00

Biodesix presently has a consensus price target of $3.06, suggesting a potential upside of 265.59%. Given Biodesix’s stronger consensus rating and higher possible upside, analysts clearly believe Biodesix is more favorable than First Choice Healthcare Solutions.

Summary

Biodesix beats First Choice Healthcare Solutions on 9 of the 12 factors compared between the two stocks.

About Biodesix

(Get Free Report)

Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR and NGS, and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.

About First Choice Healthcare Solutions

(Get Free Report)

First Choice Healthcare Solutions, Inc. provides healthcare services in the United States. It develops primary care and wellness clinics focused on providing life improvement services, such as anti-aging, weight management, hormone replacement, and pharmacy services. The company is headquartered in Melbourne, Florida.

Receive News & Ratings for Biodesix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biodesix and related companies with MarketBeat.com's FREE daily email newsletter.